Vascular NAD(P)H oxidase mediates endothelial dysfunction in basilar arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats

Atherosclerosis

Volumn 192, Issue 1, 2007, Pages 15-24

  Matsumoto, Takayuki ^a   Kobayashi, Tsuneo ^a   Wachi, Hiroshi ^a   Seyama, Yoshiyuki ^a   Kamata, Katsuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

gp91phox; Nitric oxide; Relaxation; Type 2 diabetes

Indexed keywords

ACETYLCHOLINE; APOCYNIN; CYCLIC GMP; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BASILAR ARTERY; ENDOTHELIAL DYSFUNCTION; ENZYME SUBUNIT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ACETOPHENONES; ACETYLCHOLINE; ANIMALS; ANTIOXIDANTS; BASILAR ARTERY; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; MALE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; RATS; RATS, INBRED OLETF; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 34247125222     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.06.005     Document Type: Article

References (34)

1. Faraci F.M., and Heistad D.D. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 66 (1990) 8-17
2. Faraci F.M., and Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78 (1998) 53-97
3. Laakso M., and Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 137 (1998) S65-S73
4. De Vriese A.S., Verbeuren T.J., Van de Voorde J., et al. Endothelial dysfunction in diabetes. Br J Pharmacol 130 (2000) 963-974
5. Kobayashi T., Taguchi K., Yasuhiro T., et al. Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model. Hypertension 44 (2004) 956-962
6. Kanie N., Matsumoto T., Kobayashi T., et al. Relationship between peroxisome proliferator-activated receptors (PPAR alpha and PPAR gamma) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats. Br J Pharmacol 140 (2003) 23-32
7. Kobayashi T., and Kamata K. Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats. Atherosclerosis 155 (2001) 313-320
8. Matsumoto T., Kobayashi T., and Kamata K. Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats. Am J Physiol Heart Circ Physiol 285 (2003) H283-H291
9. Pieper G.M. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31 (1998) 1047-1060
10. Kawano K., Hirashima T., Mori S., et al. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41 (1992) 1422-1428
11. Minami A., Ishimura N., Harada N., et al. Exercise training improves acetylcholine-induced endothelium-dependent hyperpolarization in type 2 diabetic rats, Otsuka Long-Evans Tokushima Fatty rats. Atherosclerosis 162 (2002) 85-92
12. Didion S.P., Lynch C.M., Baumbach G.L., et al. Impaired endothelium-dependent responses and enhanced influence of Rho-kinase in cerebral arterioles in type II diabetes. Stroke 36 (2005) 342-347
13. Erdos B., Snipes J.A., Miller A.W., et al. Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 53 (2004) 1352-1359
14. Schwaninger R.M., Sun H., and Mayhan W.G. Impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type II diabetic rats. Life Sci 73 (2003) 3415-3425
15. Matsumoto T., Yoshiyama S., Wakabayashi K., et al. Effects of chronic insulin on endothelial dysfunction of basilar arteries from established streptozotocin-diabetic rats. Eur J Pharmacol 504 (2004) 119-127
16. Faraci F.M. Oxidative stress: the curse that underlies cerebral vascular dysfunction?. Stroke 36 (2005) 186-188
17. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24 (2003) 471-478
18. Hink U., Li H., Mollnau H., et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88 (2001) e14-e22
19. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285 (2003) R277-R297
20. Matsumoto T., Sato A., Suenaga H., et al. Modulations of shear stress-induced contractile responses and agonist-induced vasodilation in hypercholesterolemic rats. Atherosclerosis 175 (2004) 31-38
21. Wang H.D., Pagano P.J., Du Y., et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 82 (1998) 810-818
22. Sugawara T., Fujii S., Zaman A.K., et al. Coronary capillary network remodeling and hypofibrinolysis in aged obese diabetic rats: implications for increased myocardial vulnerability to ischemia. Mol Cell Biochem 248 (2003) 165-170
23. Beckman J.S., Chen J., Ischiropoulos H., et al. Oxidative chemistry of peroxynitrite. Methods Enzymol 233 (1994) 229-240
24. Didion S.P., and Faraci F.M. Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. Am J Physiol Heart Circ Physiol 282 (2002) H688-H695
25. Ignarro L.J., Fukuto J.M., Griscavage J.M., et al. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from l-arginine. Proc Natl Acad Sci USA 90 (1993) 8103-8107
26. Modin A., Bjorne H., Herulf M., et al. Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiol Scand 171 (2001) 9-16
27. Jackson T.S., Xu A., Vita J.A., and Keaney Jr. J.F. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83 (1998) 916-922
28. Szocs K., Lassegue B., Sorescu D., et al. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thoromb Vasc Biol 22 (2002) 21-27
29. Wambi-Kiesse C.O., and Katusic Z.S. Inhibition of copper/zinc superoxide dismutase impairs NO-mediated endothelium-dependent relaxations. Am J Physiol Heart Circ Physiol 276 (1999) H1043-H1048
30. Ago T., Kitazono T., Kuroda J., et al. NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 36 (2005) 1040-1046
31. Sercombe R., Vicaut E., Oudart N., et al. Acetylcholine-induced relaxation of rabbit basilar artery in vitro is rapidly reduced by reactive oxygen species in acute hyperglycemia: role of NADPH oxidase. J Cardiovasc Pharmacol 44 (2004) 507-516
32. Inoguchi T., Li P., Umeda F., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
33. Sonta T., Inoguchi T., Tsubouchi H., et al. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med 37 (2004) 115-123
34. Phillips S.A., Sylvester F.A., and Frisbee J.C. Oxidative stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288 (2005) R522-R530